BIB Holdings Information

BIB is an equity ETF with a total of 257 individual holdings.

Total Holdings

Top 10 Percentage

154.22%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

68.17M

PE Ratio

n/a

Sector Allocation

No.	Symbol	Name	% Weight	Shares
1	n/a	NASDAQ BIO INDEX SWAP BNP PARIBAS	35.08%	4,796
2	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	34.65%	4,737
3	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	22.49%	3,075
4	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	18.17%	2,484
5	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	16.82%	2,299
6	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	8.45%	1,155
7	AMGN	Amgen Inc.	5.20%	11,592
8	VRTX	Vertex Pharmaceuticals Incorporated	4.85%	8,530
9	GILD	Gilead Sciences, Inc.	4.79%	29,525
10	REGN	Regeneron Pharmaceuticals, Inc.	3.72%	4,164
11	ALNY	Alnylam Pharmaceuticals, Inc.	3.14%	5,240
12	AZN	AstraZeneca PLC	2.46%	20,873
13	INSM	Insmed Incorporated	2.19%	8,520
14	ARGX	argenx SE	1.45%	1,233
15	BIIB	Biogen Inc.	1.25%	5,910
16	INCY	Incyte Corporation	1.13%	7,871
17	UTHR	United Therapeutics Corporation	1.11%	1,823
18	ILMN	Illumina, Inc.	1.01%	6,195
19	MEDP	Medpace Holdings, Inc.	0.90%	1,133
20	RPRX	Royalty Pharma plc	0.90%	17,424
21	NBIX	Neurocrine Biosciences, Inc.	0.78%	3,997
22	ROIV	Roivant Sciences Ltd.	0.76%	27,524
23	SMMT	Summit Therapeutics Inc.	0.76%	29,941
24	SNY	Sanofi	0.74%	10,815
25	VTRS	Viatris Inc.	0.70%	46,990

Showing 25 of 257 holdings

Subscribe to see the full list

As of Nov 11, 2025